Success Metrics

Clinical Success Rate
95.8%

Based on 23 completed trials

Completion Rate
96%(23/24)
Active Trials
5(11%)
Results Posted
9%(2 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
1
2%
Ph not_applicable
28
62%
Ph phase_4
5
11%
Ph phase_1
1
2%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution35 total trials
Phase 1Safety & dosage
1(2.9%)
Phase 2Efficacy & side effects
1(2.9%)
Phase 4Post-market surveillance
5(14.3%)
N/ANon-phased studies
28(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.0%

23 of 25 finished

Non-Completion Rate

8.0%

2 ended early

Currently Active

5

trials recruiting

Total Trials

45

all time

Status Distribution
Active(7)
Completed(23)
Terminated(2)
Other(13)

Detailed Status

Completed23
unknown13
Recruiting3
Not yet recruiting2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
45
Active
5
Success Rate
95.8%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (2.9%)
Phase 21 (2.9%)
Phase 45 (14.3%)
N/A28 (80.0%)

Trials by Status

terminated12%
completed2351%
not_yet_recruiting24%
recruiting37%
unknown1329%
active_not_recruiting24%
withdrawn12%

Recent Activity

Clinical Trials (45)

Showing 20 of 45 trialsScroll for more
NCT07161635Not Applicable

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

Active Not Recruiting
NCT07502456Not Applicable

Clareon TruPlus Single-Arm Study

Not Yet Recruiting
NCT07147192Not Applicable

Feasibility Study of an Accommodating IOL Design

Recruiting
NCT07369388Not Applicable

Endothelial Changes in Diabetic and Non-diabetic Patients Undergoing Phacoemulsification

Completed
NCT07252154Not Applicable

Modified Nuclear Phacoemulsification in Brown Cataract

Completed
NCT06974578Not Applicable

Capsular Tension Ring With Hydeophilic Intraocular Lesnes to Decrease Posterior Capsule Opacification Versus Hydrophobic Ones

Completed
NCT06904560Not Applicable

The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort

Not Yet Recruiting
NCT06865235Not Applicable

Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.

Recruiting
NCT06741774Not Applicable

Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO )

Active Not Recruiting
NCT06630546Not Applicable

Trabecular Microbypass IStent in Patients with Glaucoma

Completed
NCT04416724Not Applicable

Phacoemulsification vs SLT as Initial Treatment for Pseudoexfoliation Glaucoma

Recruiting
NCT05265832Not Applicable

Influencing Factors of the Corneal Endothelial Cell Loss

Completed
NCT05886283Not Applicable

Qualitative and Quantitative Endothelium Changes After Cataract Surgery: Ultrasound Phacoemulsification vs Nanolaser Technique

Completed
NCT05871034Not Applicable

Electroretinogram and Retinal Vascular Changes After Cataract Surgery

Unknown
NCT05430295Not Applicable

Visual Acuity After Using A New Monofocal Intraocular Lens Compared To Standard Monofocal Lens

Completed
NCT05447130Not Applicable

Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome

Completed
NCT05386160Phase 4

Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy

Unknown
NCT05290896Not Applicable

Correlations Between Lens Star and Phacoemulsification.

Unknown
NCT03494465Not Applicable

Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma

Completed
NCT04920227Not Applicable

Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
45